tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Dyne Therapeutics 24.2M share Spot Secondary priced at $8.25

The deal range was $8.25-$9.00. Morgan Stanley, Jefferies, Stifel and Guggenheim acted as joint book running managers for the offering.

Elevate Your Investing Strategy:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Disclaimer & DisclosureReport an Issue

1